BioCardia, Inc.
BCDA
$2.23
-$0.02-0.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.63% | -10.81% | 32.52% | 51.93% | 35.25% |
| Total Depreciation and Amortization | -36.84% | -25.00% | -23.81% | -19.05% | -13.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | -3.56% | -22.92% | -39.80% | -25.21% |
| Change in Net Operating Assets | 80.71% | -603.75% | -457.21% | 153.79% | -19.75% |
| Cash from Operations | -5.75% | -39.01% | -8.25% | 58.36% | 40.23% |
| Capital Expenditure | -- | -- | -- | -50.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -50.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -85.54% | -97.10% | 7,723.91% | -31.67% | 500.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 82.22% | 89.43% | -617.33% | 40.95% | 50.00% |
| Cash from Financing | -85.76% | -98.66% | 10,655.17% | -31.30% | 2,050.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -823.38% | -249.59% | 242.06% | 185.51% | 93.85% |